Apotheca Biosciences, Inc. CBDC Stock
Apotheca Biosciences, Inc. Price Chart
Apotheca Biosciences, Inc. CBDC Financial and Trading Overview
| Apotheca Biosciences, Inc. stock price | 0.0000 USD |
| Previous Close | 0.0002 USD |
| Open | 0.0002 USD |
| Bid | 0 USD x 0 |
| Ask | 0 USD x 0 |
| Day's Range | 0.0002 - 0.0002 USD |
| 52 Week Range | 0.0001 - 0.31 USD |
| Volume | 1K USD |
| Avg. Volume | 2.19K USD |
| Market Cap | 35.92K USD |
| Beta (5Y Monthly) | -0.42542 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
CBDC Valuation Measures
| Enterprise Value | 72.61K USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
Apotheca Biosciences, Inc. Stock Price History
| Beta (5Y Monthly) | -0.42542 |
| 52-Week Change | N/A |
| S&P500 52-Week Change | N/A |
| 52 Week High | 0.31 USD |
| 52 Week Low | 0.0001 USD |
| 50-Day Moving Average | 0.0001416667 USD |
| 200-Day Moving Average | 0.04 USD |
CBDC Share Statistics
| Avg. Volume (3 month) | 2.19K USD |
| Avg. Daily Volume (10-Days) | 858 USD |
| Shares Outstanding | 179.61M |
| Float | 81.71M |
| Short Ratio | N/A |
| % Held by Insiders | 55.11% |
| % Held by Institutions | 0% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | N/A |
| Trailing Annual Dividend Yield | N/A |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 6:1 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | January 31, 2019 |
| Most Recent Quarter (mrq) | April 30, 2019 |
| Next Fiscal Year End | January 31, 2021 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | N/A |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | -2705272 USD |
| Diluted EPS (ttm) | -0.025 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 250.48K USD |
| Total Cash Per Share (mrq) | 0.001 USD |
| Total Debt (mrq) | 322.91K USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 0.305 |
| Book Value Per Share (mrq) | -0.006 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -573134 USD |
| Levered Free Cash Flow (ttm) | N/A |
Profile of Apotheca Biosciences, Inc.
| Country | United States |
| State | FL |
| City | Saint Petersburg |
| Address | 10901 Roosevelt Boulevard North Building |
| ZIP | 33716 |
| Phone | 727-228-3994 |
| Website | https://www.apothecabiosciences.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 3 |
Apotheca Biosciences, Inc. develops cutting-edge medical products, nutraceuticals, formulations, and delivery technologies for the healthcare and consumer care industry in the United States. The company's products include transdermal, sublingual, and nasal delivery devices for dosing of cannabinoids. It also provides CBD pain cream, gel capsules, patches, and sleep tablets; and Promed, anti-aging and cosmetic products. The company was incorporated in 2014 and is based in Saint Petersburg, Florida.
Q&A For Apotheca Biosciences, Inc. Stock
What is a current CBDC stock price?
Apotheca Biosciences, Inc. CBDC stock price today per share is 0.0000 USD.
How to purchase Apotheca Biosciences, Inc. stock?
You can buy CBDC shares on the Other OTC exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Apotheca Biosciences, Inc.?
The stock symbol or ticker of Apotheca Biosciences, Inc. is CBDC.
Which industry does the Apotheca Biosciences, Inc. company belong to?
The Apotheca Biosciences, Inc. industry is Biotechnology.
How many shares does Apotheca Biosciences, Inc. have in circulation?
The max supply of Apotheca Biosciences, Inc. shares is 0.
What is Apotheca Biosciences, Inc. Price to Earnings Ratio (PE Ratio)?
Apotheca Biosciences, Inc. PE Ratio is 0.00000000 now.
What was Apotheca Biosciences, Inc. earnings per share over the trailing 12 months (TTM)?
Apotheca Biosciences, Inc. EPS is 0 USD over the trailing 12 months.
Which sector does the Apotheca Biosciences, Inc. company belong to?
The Apotheca Biosciences, Inc. sector is Healthcare.